Way Too Early

20140109-061043.jpg

I’m up way too early for a good reason.

I’m headed to the Medtronic/Bayer sponsored Diabetes Advocacy Summit to talk about… Everything. We may not get to everything but I’m hoping we will cover what is important.

Medtronic and Bayer are footing the bill for all of us. I’m grateful for the opportunity and will be sharing my thoughts and ideas on the meeting via Twitter (during) and here (after).

If you have questions, comment below or hit me up on Twitter at @theperfectdblog – thanks!

In the meantime, I’m crossing my fingers that I will get some sleep on the plane, because I have a feeling that once I see my d-family and friends, there won’t be much sleep.

0 comments
  1. Travel well, and have a great trip, Christel! While I do have some reservations about what this forum has become, I appreciate that you (and others, too) will be representing my voice there. Of course, there’s all the usual stuff – accuracy, product pipeline, frustration with the initial 530G “pitch” after FDA approval… But one thing in particular stands out to me. From the inside there, it’d be really helpful to me to be able to know SPECIFICALLY how MedT is following up on the production facility issues entailed in the FDA warning letter issued last year — from changes they’ve made in machines, to manufacturing process, to how the paperwork flows and is documented internally. Any insight that might help me (and most likely other pump/CGM users) see to help our confidence level, to know these specifics rather than vague notions of “we’ve improved,” would be very much appreciated. Thanks!

  2. I want Medtronic to take more ownership about how it’s pump users (like me) want NOTHING to do with it’s CGM because the Dexcom is better. WAY better. I would hope they could throw some market share aside (yeah, I know, doubtful) and work more towards integrating with Dexcom rather than pushing their own substandard CGM.

Leave a Reply